Follow-The-Filings

LTRN Lantern Pharma

Lantern Pharma earnings company data as of 7:18 PM ET 8/21

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS -0.57
Rev

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q
8-K 2.02,7.01,9.01
8-K 7.01,9.01
S-1
8-K 7.01,9.01
10-Q
8-K 2.02,9.01
424B5
8-K 1.01,3.02,8.01,9.01
10-K/A
8-K 7.01,9.01
8-K 2.02,7.01,9.01
10-K
424B5
8-K 7.01,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 5.02,5.03,9.01
424B5
8-K 1.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period May 12, 2026 · 2 forms
4 Period Jan 9, 2026 · 3 forms

12 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice